# OnCo record gvhd-lung-bronchiolitis-obliterans (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/gvhd-lung-bronchiolitis-obliterans/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "gvhd-lung-bronchiolitis-obliterans" ;
  schema:name "The lungs after transplant: bronchiolitis obliterans syndrome"@en ;
  schema:alternateName "bronchiolitis obliterans syndrome"@en, "BOS"@en, "pulmonary GvHD"@en, "obliterative bronchiolitis after transplant"@en ;
  schema:description "The smallest airways in the lung can scar shut after a donor transplant. It is the form of chronic GvHD that changes the outlook most, and it is usually silent until a lot of lung function has gone. It is found by breathing tests on a schedule rather than by waiting for breathlessness, so asking for spirometry is worth doing."@en ;
  schema:url <https://onco.cc/technologies/gvhd-lung-bronchiolitis-obliterans/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bronchiolitis_obliterans> ;
  schema:citation <https://doi.org/10.1016/j.bbmt.2014.12.001>, <https://doi.org/10.1016/j.jtct.2023.09.016>, <https://doi.org/10.1016/j.bbmt.2011.12.519>, <https://doi.org/10.1056/NEJMoa2033122>, <https://doi.org/10.3324/haematol.2016.150250> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "transplant", "gvhd", "lung" ;
  onco:related <https://onco.cc/technologies/gvhd-chronic-overview/>, <https://onco.cc/technologies/gvhd-nih-consensus-criteria/>, <https://onco.cc/technologies/gvhd-organ-by-organ/>, <https://onco.cc/technologies/gvhd-ruxolitinib-steroid-refractory/>, <https://onco.cc/technologies/rejuv-tx-bone-eyes-kidneys-lungs/>, <https://onco.cc/technologies/rejuv-tx-long-term-follow-up-frameworks/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/total-body-irradiation/> ;
  onco:terms <https://onco.cc/terms/gvhd/>, <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> .